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Abstract
Glucose-dependent insulinotropic polypeptide (GIP) in combination with hyperinsulinemia 
increase blood flow and triglyceride clearance in subcutaneous abdominal adipose 
tissue in lean humans. The present experiments were performed to determine whether 
the increase involves capillary recruitment. Eight lean healthy volunteers were studied 
before and after 1 h infusion of GIP or saline during a hyperglycemic–hyperinsulinemic 
clamp, raising plasma glucose and insulin to postprandial levels. Subcutaneous abdominal 
adipose tissue blood flow (ATBF) was measured by the 133Xenon clearance technique, and 
microvascular blood volume was determined by contrast-enhanced ultrasound imaging. 
During infusion of saline and the clamp, both ATBF (2.7 ± 0.5 mL/min 100 g/tissue) and 
microvascular blood volume remained unchanged throughout the experiments. During 
GIP infusion and the clamp, ATBF increased ~fourfold to 11.4 ± 1.9 mL/min 100 g/tissue, 
P < 0.001. Likewise, the contrast-enhanced ultrasound signal intensity, a measure of the 
microvascular blood volume, increased significantly 1 h after infusion of GIP and the clamp 
(P = 0.003), but not in the control experiments. In conclusion, the increase in ATBF during 
GIP infusion involves recruitment of capillaries in healthy lean subjects, which probably 
increases the interaction of circulating lipoproteins with lipoprotein lipase, thus promoting 
adipose tissue lipid uptake.
Introduction
The regulation of subcutaneous adipose tissue blood flow 
(ATBF) is crucial in lipid homeostasis (1, 2). It has long 
been recognized that the ATBF is tightly coupled to adipose 
tissue metabolism (3, 4, 5, 6). In response to feeding, an 
increase in ATBF is seen in healthy subjects (4). GIP is 
involved in the increase of ATBF in healthy subjects (7, 8, 
9). GIP is a polypeptide hormone that is secreted from the 
small-intestinal K cells in response to nutrient intake (10). 
GIP is well founded as an incretin hormone potentiating 
insulin release from β-cells in healthy humans (10, 11, 12). 
In addition to its insulinotropic effects, we have 
previously shown that GIP infusion during physiological 
hyperglycemia and hyperinsulinemia increases ATBF 
and stimulates glucose uptake and triacylglycerol (TAG) 
deposition in adipose tissue in lean humans (7). In contrast, 
in these experiments neither GIP nor hyperinsulinemia 
per se had any effect on ATBF. Subsequent studies in lean 
healthy subjects demonstrated that insulin is essential for 
GIP to increase ATBF and adipose tissue TAG clearance 
(9). In obese humans with impaired glucose tolerance, 
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GIP infusion in combination with hyperglycemia and 
hyperinsulinemia did not induce any changes in ATBF and 
TAG uptake in adipose tissue (13). However, weight loss 
(mean weight loss: 7.5 kg) induced by caloric restriction in 
obese humans with impaired glucose tolerance, resulted 
in improved insulin sensitivity and partly restored the 
vasodilatory effect of GIP and insulin during otherwise 
comparable experimental conditions (8). Recently, we 
demonstrated that the circulatory and metabolic effects of 
GIP in adipose tissue can be blocked by a truncated form 
of human GIP, GIP (3-30)NH2, which is a high-affinity 
competitive antagonist of the human GIP receptor (14). In 
addition, we have previously shown that in subcutaneous 
abdominal adipose tissue of healthy lean subjects, there is 
an increased capillary recruitment in response to an oral 
glucose load, as indicated by an increased microvascular 
blood volume (15). The recruitment of capillaries will 
expose a larger amount of the circulating triacylglycerol 
particles to the endothelial lipoprotein lipase (LPL), 
increasing the hydrolysis of these particles. This, in turn, 
will give rise to an enhanced free fatty uptake in adipose 
tissue. Thus, the aim of this study was to elucidate whether 
the effects of GIP on ATBF and lipid metabolism involves 
capillary recruitment in healthy lean subjects.
Materials and methods
Subjects
Eight healthy non-smoking males were studied. The 
anthropometric characteristics, subcutaneous adipose 
tissue thickness, body fat composition, lipid and glucose 
profile are summarized in Table  1. The subjects also 
took part in a recent, reported study (14). None of the 
subjects had a positive family history of diabetes. All 
had normal fasting blood concentrations of glucose, 
lipids and hemoglobin and normal renal and hepatic 
functions. All subjects gave informed written consent 
to participate. The protocol was approved by the Ethical 
Committee of Copenhagen Municipality (H-2-2010-079), 
and the study was performed in accordance with the 
Helsinki Declaration II.
Experimental design
The study protocol had a cross-over design with a washout 
period of at least 2  weeks. Each subject served as his 
own control and was studied, in a randomized order, on 
two different occasions during infusion of GIP 
(1.5 pmol/kg/min) or saline during 60 min – both days 
in combination with physiological hyperglycemic–
hyperinsulinemic (Hygluc-Hyins) clamps, raising plasma 
glucose and insulin to postprandial levels.
Protocol
The subjects were instructed to abstain from drinking 
alcohol or doing strenuous physical activities for 2 days 
prior to the experiments to ensure equally filled glycogen 
stores. On the days of the experiments, subjects arrived 
at the department at 08:00 h having used non-strenuous 
transportation and after having fasted for at least 12 h. The 
investigations were performed with the subjects in supine 
position in a room kept at 24°C. A catheter (BD Venflon, 
TMPRO, Becton Dickinson, Singapore) was inserted into 
an antecubital vein for the infusion of GIP, saline, glucose, 
insulin and SonoVue (see below).
After baseline measurements (time −30, −15 and 
0 min) a continuous infusion of either GIP or saline in 
combination with the clamp were commenced.
GIP infusions and the clamp
GIP
Synthetic human GIP (1–42) was purchased from Bachem 
(Bubendorf, Switzerland) and demonstrated to be >97% 
pure and identical to the natural human peptide by 
HPLC, mass and sequence analysis. GIP was dissolved in 
saline containing 0.5% human serum albumin (Human 
Albumin, CSL Behring, Marburg, Germany) and subjected 
to sterile filtration.
Hygluc-Hyins clamp
The objective of the Hygluc-Hyins clamp was to increase 
plasma glucose levels above fasting levels (6.5–7 mM) and 
Table 1 Anthropometric characteristic, lipid and glucose 
profile of studied male subjects.
Characteristics Mean ± s.d.
Age (years) 26.4 ± 2.3
Height (cm) 182.4 ± 5.1
Body weight (kg) 76.5 ± 7.6
BMI (kg/m2) 22.9 ± 1.4
Subcutaneous fat (cm) 2.6 ± 0.3
Fat mass (%) 18.9 ± 4.3
Triacylglycerides (mM) 1.0 ± 0.5
HDL (mM) 1.5 ± 0.2
LDL (mM) 1.9 ± 0.4
Cholesterol (mM) 4.0 ± 0.4
HbA1c (mmol/mol) 31 ± 1.4
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to increase insulin concentration to postprandial levels. 
The protocol included: (1) a continuous, variable glucose 
infusion (the infusion rate was adjusted every 5–10 min 
according to measured plasma glucose to maintain 
the glucose concentration at the desired target); and 
(2) during saline infusion, insulin (Actrapid Human; 
Novo Nordisk) was infused at a continuous rate of 
10 mU/m2/min. During concomitant GIP infusion, 
insulin infusion rate was adjusted according to the 
expected endogenous insulin secretion in response to 
GIP aiming toward plasma insulin levels comparable to 
those obtained during insulin infusion alone. Therefore, 
insulin was infused at a lower rate 7 mU/m2/min under 
these conditions.
Contrast-enhanced ultrasound imaging and 
image analysis
Contrast-enhanced ultrasound imaging has previously 
been validated in our laboratory and is a reliable 
method to estimate the microvascular blood volume in 
human subcutaneous abdominal adipose tissue (15). An 
ultrasound transducer was placed vertically and each 
time at the same side of the abdomen approximately 
5 cm above the iliac crest and at the para-umbilical area 
in the mid-clavicular line. The location of the transducer 
was highlighted before the infusions were started; thus, 
it was possible to use the same location later (1 h after 
the start of infusions). The transducer was held in a fixed 
position and the subjects were instructed not to change 
body position during the measurements. At baseline 
and 1 h after GIP or saline infusion, a bolus of 2.5 mL 
of the ultrasound contrast agent (SonoVue Bracco S.p.A, 
Milan, Italy) was injected intravenously followed by an 
immediate flush of 10 mL 0.9% saline solution. SonoVue 
is a suspension of phospholipid-stabilized microbubbles 
filled with hexafluoride; it is diluted with 4.5 mL 0.9% 
saline solution before injection (8 µL microbubbles/mL). 
Ultrasound scanning was performed using a linear array 
transducer (L9-3 MHz) and an iU22 ultrasound scanner 
(Phillips Medical Systems, Bothell, WA, USA). B-mode 
imaging is created from broadband spectra of acoustic 
frequencies from 3 to 9 MHz. Contrast first harmonic 
signals were received at 8 MHz with mechanical index of 
0.06. The depth was set at 3 cm allowing for measurements 
in subcutaneous abdominal adipose tissue. Focus and 
gain were optimized at the beginning of the experiment 
and held constant throughout. Twenty millisecond 
images were captured consecutively for 2 min after each 
bolus injection.
Image analysis was performed off-line using an 
ultrasound quantification and analysis software (QLAB 
version 7; Phillips Medical Systems). The analysis consisted 
of examination of region of interest (ROI) for each recording 
in the subcutaneous abdominal adipose tissue. The ROI 
placements were in areas that excluded larger vessels 
during the enhancement phase. In a ROI, the relative 
microvascular blood volume expressed in Δ decibels (dB) 
in the tissue was determined as the mean signal intensity 
in dB during the first plateau phase after subtraction of the 
mean signal intensity registered immediately before the 
contrast bolus injection, Fig. 1 (16).
Determination of ATBF
ATBF in the subcutaneous abdominal adipose tissue 
contralateral to the ultrasound transducer position 
was determined during the whole experiment by 
recording washout of 133Xenon, which was injected in 
gaseous form into the adipose tissue. This technique 
has previously been validated in our laboratory (17). 
About 1 MBq gaseous 133Xenon mixed in about 0.1 mL 
of atmospheric air was injected into the para-umbilical 
area of the subcutaneous abdominal adipose tissue. The 
washout rate of 133Xenon was measured continuously by 
a scintillation counting device placed over the exact site 
of injection and fixed firmly in place (Mediscint, Oakfield 
Instruments, Oxford, UK). The ATBF was calculated from 
the mean washout rate constant determined in 30 min 
periods corresponding to the time points when blood 
samples were drawn. A tissue/blood partition coefficient 
for 133Xenon of 10 mL/g was used. In order to detect early 
flow changes, a monoexponential curve was fitted to 
the washout curve registered in the basal control period 
Figure 1
A curve from the subcutaneous abdominal adipose tissue after 
administration of a bolus of the ultrasound agent SonoVue® in one 
subject. The first-phase plateau level is used for the calculation of the 
microvascular blood volume.
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immediately before the hormone infusions were initiated. 
The commencement of the vascular effects was defined 
when the slope of the 133Xenon-washout curve deviated 
from the baseline slope by visual inspection.
Blood samples
Arterial blood samples were drawn at times −30, −15, 0, 30 
and 60 min. Blood samples were collected in iced chilled 
tubes (Vacuetta; Greiner Labortechnic, Kremsmünster, 
Austria) from the artery for measurements of GIP and 
insulin. Tubes for total GIP contained EDTA and tubes for 
insulin contained heparin. All samples were centrifuged 
within 15 min for 15 min at 5000 g at 4°C and stored at 
−80°C until analysis.
Blood analysis
Total plasma GIP concentrations were measured using 
a C-terminally directed antibody (18). Plasma insulin 
concentrations were measured by auto-DELPHIA 
automatic fluoroimmunoassay (14). Plasma glucose 
concentrations were measured bedside during the clamp 
experiments, using the Radiometer ABL 725 blood gas 
analyzer (Radiometer Corp., Brønshøj, Denmark).
Calculations and statistical analysis
The ATBF was calculated from the mean washout rate 
constant determined in 30-min periods corresponding 
to the time points when blood samples were drawn. 
ATBF was then calculated according to the equation 
ATBF = −k × λ × 100, where k is the washout constant 
and λ is the tissue/blood partition coefficient (λ) for 
133Xenon.
Sample size was determined before the study using 
power analysis (P = 0.8, α = 0.05) with regard to ATBF 
responses based on our previous publications (7, 8, 9, 13, 
14). Assuming an ATBF response as found previously in 
normal weight, healthy subjects, less than six subjects 
were needed in the present study.
All results are presented as mean ± s.e.m. The 
significance of changes in ATBF with time was evaluated 
using two-way ANOVA for repeated measures. Changes 
in ultrasound signal intensity from baseline during GIP 
and saline infusions were compared, using paired t test 
(two-tailed). P values of <0.05 were considered statistically 
significant. The Spearman correlation test was used to 
calculate the correlation between ATBF and microvascular 
blood volume.
Data were analyzed using GraphPad Prism 8 
(GraphPad Software, Inc., La Jolla, CA, USA).
Results
Arterial glucose, insulin and GIP concentrations
Figure  2 shows plasma glucose, insulin and total GIP 
concentrations during GIP and saline. The concentrations 
of glucose, insulin, GIP during infusion of GIP have been 
a part of our recently published study (14), however, 
in the present study, besides baseline concentrations, 
only the concentrations during the first hour after 
commencement of GIP infusion and the clamps are 
shown and described, corresponding to the time capillary 
recruitment was measured. The clamps were carried out 
successfully. Plasma glucose levels reached the target 
levels of 6.8 ± 0.1 and 6.9 ± 0.1 mM 30 min after start of the 
infusion of GIP and saline, respectively, Fig. 2A. There was 
no significant difference between the amounts of glucose 
infused during these two experiments (27 ± 5 and 17 ± 3 g, 
P = 0.2), reflecting similar insulin levels during the two 
experiments. Plasma insulin levels increased significantly 
and reached levels of 404 ± 8 and 358 ± 15 pM 30 min 
after the start of infusion of GIP and saline, respectively, 
Fig. 2B, P = 0.1.
During GIP infusion, total plasma GIP concentrations 
increased significantly from fasting levels (9.9 ± 0.3 pM) 
and after approximately 30 min reached mean plateau 
levels of 120 ± 7 pM, whereas plasma GIP levels remained 
unchanged and at fasting levels during saline infusion 
(8.1 ± 0.9 pM), (Fig. 2C).
Changes in subcutaneous abdominal ATBF
Figure 3 shows the subcutaneous abdominal ATBF during 
the two experiments. Baseline ATBF did not differ between 
the two studies (2.6 ± 0.6 and 2.5 ± 0.5 mL/100 g/min)). 
ATBF during GIP infusion has been described in our recent 
study (14) but in the present study only ATBF during the 
first hour after commencement of infusion of GIP and the 
clamps are shown and described. During GIP infusion ATBF 
increased fourfold to a mean level of 11.4 ± 1.9 mL/100 g/min 
(P = 0.004), whereas ATBF remained unchanged during saline 
infusion (2.7 ± 0.5 mL/100 g/min).
Changes in microvascular blood volume
During the two experiments, baseline ΔdB signal 
intensities were almost similar (2.1 ± 0.3 and 1.5 ± 0.3 dB, 
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respectively, P = NS, Fig.  4A and B). After 60 min of GIP 
infusion, the ΔdB signal intensity increased significantly 
(3.6 ± 0.4 dB Fig.  4A, P = 0.003), whereas no change was 
seen in the saline study (1.6 ± 0.2 dB, Fig. 4B).
There was a significant correlation between 
microvascular blood volume and ATBF during GIP 
(r = 0.85 and P = 0.01). No correlation was seen during 
saline (r = 0.34 and P = 0.5)
Discussion
ATBF has a fundamental role in the regulation of the 
adipose tissue metabolism (4). We have previously shown 
in several studies that infusion of GIP in combination 
with insulin increase ATBF up to fivefold (7, 9, 14). In 
line with these findings we now show that the increase 
in ATBF during GIP and insulin plasma levels identical 
to those reached postprandially involves capillary 
recruitment. The phenomenon, capillary recruitment, has 
long been recognized in the skeletal muscle (19, 20, 21). 
Few studies have suggested that adipose tissue possesses 
the ability of capillary recruitment (15, 22). However, in 
the postprandial period, adipose tissue metabolism is, at 
least in part, dependent on increase in the macrovascular 
and microvascular perfusion rate (23). The increase in 
blood flow in adipose tissue following feeding parallels 
that of plasma GIP and insulin concentrations (24). 
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Figure 2
Plasma glucose (A), insulin (B) and GIP (C) concentrations during 
Hygluc-Hyins clamp with GIP infusion (open circle) and saline (solid circle). 
Data are mean ± s.e.m.
Figure 3
Subcutaneous abdominal adipose tissue blood flow during Hygluc-Hyins 
clamp with GIP infusion (open circle) or saline (solid circle). Data are 
mean ± s.e.m.
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Several mechanisms influence the regulation of 
the postprandial ATBF in humans (23). In humans, 
adrenergic mechanisms are dominating, with β1-receptor-
mediated vasodilatation (3, 6) and α2-receptor-mediated 
vasoconstriction being the main regulators (25). The 
blood flow response to feeding is blocked by propranolol 
infusion (completely in some adipose tissue depots and 
partially in others) (6), suggesting that it is dependent 
upon sympathetic activation. The mechanisms behind 
the induction of the capillary recruitment in the adipose 
tissues are yet unknown, but a study from our laboratory 
showed that infusion of adrenaline increased both ATBF 
and capillary recruitment (26).
In human and animal studies, insulin exerts vascular 
actions in skeletal muscle, increasing blood flow and 
glucose disposal (27, 28). It recruits microvasculature in the 
muscle by relaxing terminal arterioles thereby expanding 
the microvascular blood flow (20, 21, 29). Furthermore, 
insulin induces relaxation of resistance vessels and causes 
an increase of overall blood flow (27, 30). The insulin-
induced microvascular recruitment in muscle is mainly 
mediated by nitric oxide (NO) (31). NO exerts a major 
role in vascular biology by regulating vascular tone and 
mediating vasodilation (32). The same pathway may 
also be relevant for GIP’s action in the adipose tissue 
microvasculature, as the GIP-induced vasodilatory actions 
appear to be mediated via endothelium-dependent NO 
production (33). In the present study hyperinsulinemia 
per se did not have any effect on neither the ATBF 
nor the adipose tissue microvascular blood volume. 
These findings are in accordance with our previous studies 
in which we found that neither insulin nor GIP per se had 
any effect on ATBF but that GIP in the presence of insulin 
above a certain concentration increased ATBF and adipose 
tissue TAG deposition (7). Administration of even larger 
amounts of insulin did not elicit further increase in ATBF 
indicating that insulin exerts a permissive but not additive 
role for the vasodilatory effect of GIP (9). This effect of 
GIP is most likely receptor mediated as it can be abolished 
when antagonizing the human GIP receptor (14). GIP 
receptors are found also in human adipose tissue (34) 
and recent studies indicate that GIP receptor expression 
in subcutaneous adipose tissue is inversely associated 
with BMI (35, 36).
Interestingly, the other incretin hormone, glucagon-
like-peptide-1 (GLP-1), also increases total blood flow in 
adipose tissue in healthy subjects, however, with a delay 
compared to the effect of GIP (37). Furthermore, GLP-1 
has been shown to increase microvascular recruitment 
in human and rat muscle (38). Whether GLP-1 also 
increases microvascular recruitment in adipose tissue 
remains to be elucidated.
In the postprandial state, the adipose tissue’s metabolic 
role is primarily to deposit circulating triglycerides (1). As 
the enzyme LPL is bound to the adipose tissue capillaries, 
the capillary recruitment, that is enlarged vascular surface 
area in the adipose tissue will increase the exposure of 
the circulating lipoproteins to the enzyme and lead to a 
postprandial increased lipid deposition in the adipose 
tissue, at least in healthy subjects (1). This coupled with 
our previous findings (7, 9, 14), where we found an increase 
in TAG hydrolysis, FFA re-esterification and glucose 
uptake, is consistent with a coordinated GIP response in 
adipose tissue resulting in increased TAG deposition in 
subcutaneous abdominal adipose tissue via the conversion 
of glucose to alpha-glycerol-phosphate to esterify the free 
fatty acids derived from the TAG hydrolysis.
In conclusion, subcutaneous adipose tissue capillaries 
are recruited simultaneously with increased ATBF in 
response to GIP with insulin in healthy lean subjects, thus 
increasing the exposure of LPL to its substrate.
Figure 4
Signal intensity changes from baseline to first-phase plateau (ΔdB) in 
subcutaneous abdominal adipose tissue before and 1 h after Hygluc-Hyins 
clamp with (A) GIP and (B) saline.
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